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ABSTRACT 
Dendritic cells (DC) are professional antigen-presenting cells that act as a “bridge” between innate and 
adaptive immunity by the induction and subsequent orchestration of immune responses. The ligation of 
Toll-like receptors (TLR) and other innate receptors on DC determines their immune-stimulating 
capacity. In the studies included in this thesis, TLR activation of DC and the different aspects of such 
activation were investigated. In paper I, we explored how low physiological temperatures, commonly 
found in the skin where DC reside, affect DC activation and function. We found that several cellular 
functions, including macropinocytosis, phagocytosis, podosome formation, migration, and antigen 
processing, were similar for unstimulated DC at 28°C and 37°C. However, when DC were stimulated 
with the TLR agonist LPS at 28°C the kinetics of macropinocytosis and TNF production were delayed. 
These altered responses are most likely explained by the observed delay in the kinetics of TLR signalling, 
e.g., via the MAPK signalling pathway at 28°C. In addition, other functions of DC were more severely 
affected by the low temperature, including a reduction in NO production, CD40 receptor upregulation, 
and degradation of the extracellular matrix by podosomes. Also, the capacity of DC to activate T-cells 
was reduced after TLR activation at 28°C. These data provide new insights into an area of DC biology 
with potential relevance for vaccine development. 
 
Cellular migration involves as series of events including the formation of podosomes, which are highly 
dynamic actin-filament scaffolds. In paper II, we examined the role of the actin-severing and capping 
protein gelsolin for podosom formation and function in DC. For this purpose, DC from mice deficient in 
gelsolin were used. In contrast to what was previously shown for osteoclasts, we found that DC form 
podosomes independently of gelsolin. Moreover, the formation and disassembly dynamics of podosomes 
are normal in DC deficient in gelsolin, as is their matrix-degrading function. Furthermore, we found that 
gelsolin is not required for TLR4-induced podosome disassembly. The actin cytoskeleton of podosomes 
involved in DC extracellular matrix degradation thus appears to be regulated in a different manner to the 
cytoskeleton in osteoclast podosomes that mediate bone resorption. 
 
In order to ingest particulate material via phagocytosis, for example apoptotic cells and microbes, DC 
depend on rearrangement of the actin cytoskeleton. It is known that upon pathogen recognition by TLR, 
DC undergo rapid actin cytoskeleton rearrangements. However, most studies on TLR stimulation and 
phagocytosis have focused on posttranscriptional effects, i.e., the upregulation of receptors involved in 
phagocytosis, rather than how the process of phagocytosis is affected directly after TLR activation. In 
paper III, we report that the stimulation of DC using soluble TLR ligands increased their capacity to 
phagocytose various substrates within minutes. These included polystyrene beads, sheep red blood cells, 
and apoptotic lymphoma B cells. We also found that signalling through both of the TLR4 adaptor 
molecules, MyD88 and TRIF, was necessary for optimal LPS-stimulated phagocytosis. Furthermore, we 
confirmed that stimulated phagocytic uptake proceeds independently of gene transcription, as 
actinomycin D, which blocks gene transcription, had no effect on the stimulated uptake. In summary, our 
data suggest that soluble TLR ligands induce enhanced phagocytic uptake, proximal to gene transcription. 
Thus, our study provides new information about the role of TLR engagement in modulating the 
phagocytic capacity of DC. 
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GENERAL INTRODUCTION 
 
The immune system is a remarkable defence mechanism found in all animals and it is 
constantly challenged by a myriad of surrounding potentially pathogenic 
microorganisms. Upon recognition of microorganisms the immune system can make 
rapid, highly specific, and often protective response against pathogens. Dendritic cells 
(DC) serve to orchestrate a repertoire of immune responses, linking innate and adaptive 
immunity [1-3]. The cells of the innate immune system, e.g., DC, neutrophils, and 
macrophages, detect conserved features of microbes using germ-line encoded pattern 
recognition receptors (PRR), such as the toll-like receptors (TLR), thus enabling these 
cells to respond rapidly but with limited specificity. In contrast, cells of the adaptive 
immune system, i.e., B and T cells, which generate receptors for antigen recognition de 
novo, respond later but with high specificity. In addition to recognize and respond to 
foreign molecules, the immune system also learns how to be tolerant to self. There is 
evidence supporting that DC are important in controlling inflammation-induced 
immunopathology through the generation of antigen-specific regulatory T cells. This 
includes the induction of IL-10 or TGF-! producing regulatory T cells that dampening 
immune effector mechanisms [4, 5]. Thus, DC partake in the induction of effective 
immunity against invading pathogens, as well as in preventing excessive inflammation 
and tissue pathology. Having a central role in orchestrating immune responses, DC are 
considered as potential targets for therapeutic interventions for a wide array of diseases 
[6]. Hence, discovering more about their biology is key. The aim of my thesis work 
was to increase the understanding of some aspects of DC biology, with a focus on 
innate activation and the subsequent effects of such activation.  To better understand 
the concepts discussed in this thesis, and as an attempt to set the data presented herein 
in relation to previous studies, a brief overview of the field of study is presented below. 
For a more comprehensive description of the immune system I recommend Janeway's 
immunobiology [7].  
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DENDRITIC CELL BIOLOGY 
 
The first observation of DC was made in the late 1880s by Paul Langerhans as he 
mistakenly identified these cells, residing in the epidermis, as cells of neurological 
origin and named them Langerhans cells [8, 9]. Dendritic cells as we recognize them 
today, however, were discovered in the early 1970s by Ralph Steinman, who showed 
that the DC are effective accessory cells involved in the priming of the adaptive 
immune response [10, 11]. It was not realized until later that the Langerhans cells 
present in skin are a distinct DC subpopulation [12, 13]. In many aspects, the 
Langerhans cells have become the archetypical DC. In fact, the DC life cycle that is 
most often described, also in this thesis, is often referred to as the “Langerhans cell 
paradigm” [14-16] (Figure 1). Dendritic cells in peripheral tissues, e.g., skin, express 
cellular receptors that allow the identification of microbes. In response to microbial 
stimuli DC undergo a process of cellular activation leading to cellular differentiation, a 
process termed maturation [17-19]. Upon maturation, DC transiently increase their 
capacity to internalize antigens, which is followed by increased migration and enhanced 
T cell stimulatory capacity [19, 20]. The maturing DC migrate from the periphery, via 
the lymphatics into the T cell-rich areas of lymph nodes, where they activate naïve T 
cells and direct the functional differentiation of antigen-specific effector T cells of 
various types (e.g. Th1, Th2, Th17 cells).  
 
Since the first evidence of the capacity of DC to induce immunity, was found, 
numerous studies using a wide array of experimental approaches have supported the 
notion of a pivotal role of DC in the initiation of adaptive immunity. However, the 
unique capacity of DC to activate naïve T cells has been challenged by studies which 
demonstrated that also other cell types such as macrophages, osteoclast, mast cells, and 
basophils also have the capacity to induce T-cell responses under certain conditions 
[21-27]. Although other cell types might have such a capacity to stimulate T cells, the 
consensus is that DC are unique in their capacity to prime naïve T cells and initiate 
primary T cell-mediated immune responses [16].  
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Figure 1. Schematic picture describing the “Langerhans cell paradigm”.  
 
Dendritic cells originate from haematopoietic bone marrow progenitors and are widely 
distributed throughout the body. Facultative DC progenitors are not restricted to the 
bone marrow but can be found in numerous locations in the body, e.g., the thymus, 
most visceral organs, and in the circulation [28-30], as reviewed by Alvarez et al. [31]. 
In the early studies by Steinman and others during the late 1970s and during the 1980s, 
DC were isolated from many different tissues, such as blood and peripheral lymphoid 
organs, using different techniques. However, it was difficult to obtain large yields of 
DC and due to the experimental limitations of the time, it was hard to exclude the 
possibility that other cell types were responsible for the immune stimulatory capacity of 
DC. When an in vitro system that allows the generation of large numbers of DC was 
described, using the granulocyte-macrophage colony-stimulating factor (GM-CSF) 
with or without IL-4, the field of DC biology underwent a rapid expansion [32, 33]. 
This new technique was pivotal since it made it easy to generate a large number of 
immature primary DC that could be investigated in much greater detail. 
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Are DC superior to other APC in the activation of naïve T cells? 
 
Early data suggested that DC were cells with a superior capacity to stimulate both CD4+ 
and CD8+ T-cell proliferation [34-38], compared to other antigen-presenting cells 
(APC) such as B cells and macrophages [11, 39, 40]. This notion was further solidified 
in the early 2000s, when Jung and colleagues studied the role of DC in initiating 
immunity in mice expressing the simian diphtheria toxin receptor (DTR) in DC under 
the control of the CD11c promoter (CD11c-DTR). This enables the “selective” 
depletion of DC when injecting the diphtheria toxin [41].  The authors used this 
technique to show that mice lacking CD11c+ cells were unable to mount CD8+ T-cell 
responses towards the intracellular bacterium Listeria monocytogenes or the malaria 
parasite Plasmodium yoelii [41].  In the years that followed, these data were further 
strengthened by several other studies. By using this technique, it was also shown that 
DC are important in induction of the immune response when infected with 
Mycobacterium tuberculosis, experimental cerebral malaria, and Herpes simplex virus 
[42-44]. It was also shown that DC are important for secondary immune responses 
towards L. monocytogenes, Vesicular stomatitis virus, and Influenza virus [45]. When 
considering data obtained using the CD11c-DTR experimental model it is important to 
mention that several cell types other than DC express low levels of CD11c, e.g., NK 
cells and some macrophages, which can also lead to the depletion of these cells. 
Therefore, caution is needed when interpreting these results. However, the wealth of 
data from both in vivo and in vitro studies, using isolation techniques, in vitro derived 
DC, and the CD11c-DTR-depletion system, collectively points to the fact that DC have 
key roles in immune regulation, both in the case of infection and during steady state 
homeostasis.  
 
 
Dendritic cell expression of PRR 
 
In peripheral tissues, such as the skin, Langerhans cells and dermal DC reside in an 
immature state, probing their surroundings using PRR, which recognize pathogen-
associated molecular patterns (PAMP) and danger-associated molecular patterns 
(DAMP). Innate immune cells, such as the DC, use a limited numbers of germ-line 
encoded receptors specific for conserved molecular structures expressed on microbes to 
recognize invading pathogens, whereas the adaptive immune system uses randomly 
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generated, highly specific receptors that are clonally expressed to fight infection [46, 
47]. The PRR consist of a growing number of receptor families, such as the membrane 
bound Toll-like receptors (TLR) and C-type lectin receptors (CLR), and the 
cytoplasmic NOD-like receptors (NLR) and the RIG-like receptors (RLR). Of note, 
there is emerging evidence to suggest that cross-talk between PPR families is key in 
shaping pathogen-specific responses [48]. Dendritic cells uses their TLR to sense their 
surroundings when they patrole the barrier surfaces of the body in search of invading 
microbes [49]. The TLR are the most frequently studied family of the PRR and they are 
also the focus of the studies herein.  
 
 
Toll-like receptors and signalling 
 
The TLR are a class of membrane spanning receptors that recognize conserved non-self 
molecules derived from microbes such as viruses and bacteria. In the mid-1990s, Jules 
Hoffmann and co-workers showed that the “toll” gene was involved in the immune 
response against fungi in fruit flies [50]. Subsequent studies by Medzhitov and Janeway 
in mice showed that TLR signalling induced the activation of genes involved in the 
adaptive immunity [51]. In a study the year after, in 1998, Bruce Beutler and colleagues 
showed for the first time that a mutation in the TLR4 gene, render mice (C3h/HeJ 
mice) unresponsive to the bacterial product lipopolysaccharid (LPS) [52]. This showed 
that mammalian cells have germ-line encoded receptors that recognize non-self 
microbially derived products. In 1989 Janeway had already hypothesized that because 
of the randomly generated antigen recognition receptors used by the adaptive immune 
system it could not reliably distinguish between self and non-self. Hence, Janeway 
hypothesized that the adaptive immune cells must be instructed of the origin of the 
antigen in order to elicit an appropriate immune response to clear infections and at the 
same time protect from autoimmunity [53]. He argued that this instruction might be 
provided by the innate immune system, which at that time was relatively understudied. 
Since then much data have supported his hypothesis [54]. To date, 13 different TLR 
receptors have been observed in mice and 10 in humans, many of which are expressed 
by DC [55]. The localization of TLR seems to differ depending of which molecules 
they recognize: TLR1, 2, 4, 5, and 6 are all present on the surfaces of the cells, 
recognizing molecules on the surfaces of the microbes, whereas TLR3, 7, 8, and 9 all 
reside intracellularly on membranes, recognizing nucleic acids (Figure 2). Emerging 
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evidence suggests that the localization and trafficking of TLR are key for the initiation 
of adequate responses to microbes, and is reviewed elsewhere [56].  
 
 
Figure 2. Schematic picture describing the localization of TLR. 
 
At the molecular level, TLR activation can trigger two distinct, but to some degree 
overlapping, intracellular signalling pathways through the recruitment of 
Toll/interleukin-1 receptor-like domain (TIR)-containing adaptor molecules to the TIR 
domain of the TLR. Binding of the adaptor protein MyD88 leads to downstream 
signalling events that activate nuclear factor-kappa B (NF-!B), leading to the 
transcription of genes encoding pro-inflammatory cytokines and chemokines. The TIR-
domain-containing adaptor protein-inducing interferon (TRIF)-dependent pathway 
leads to the activation of genes involved in the production of IFN-! [57-59]. Toll-like 
receptor 4 is the only TLR that signals via both MyD88 and TRIF. Most other TLR 
only signal via MyD88, with one exception: TLR3, which utilizes TRIF signalling to 
activate NF-!B and interferon-regulatory factor 3 (IRF3) [56, 60]. Interestingly, it has 
recently been shown that signalling through MyD88 and TRIF pathways down-stream 
of TLR4 is spatially and temporally separated [57]. The actvation of TLR4 first induces 
TIR domain-containing adaptor protein (TIRAP)/Mal-MyD88 signalling at the plasma 
membrane to initiate NF-!B and it is then endocytosed to activate TRIF-related adaptor 
molecule- (TRAM)-TRIF signalling from early endosomes to initiate IRF3 [57].  
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Consequences of TLR ligation for DC function 
 
Our understanding of how microbial and inflammatory stimuli affect and regulate the 
function of DC is continuously developing, as reviewed in [61-63]. At the site of 
infection DC start to produce inflammatory cytokines, e.g., TNF and IL-1!, and 
participate in recruiting other immune cells to the site of infection by producing 
chemokines [64]. It is now clear that TLR signalling not only induces the production of 
cytokines, chemokines, and co-stimulatory molecules, but it also leads to the activation 
of a numerous of changes in the cytoskeleton and vacuolar system, and also protein 
degradation. The first studies to examine the effects of TLR stimulation in DC with 
LPS on DC functions such as antigen capture and presentation were performed in the 
late 1990s [65, 66]. It has since been shown that in DC, endocytic activity is transiently 
increased upon TLR stimulation [67, 68]. Furthermore, West et al. showed that the 
simultaneous exposure to antigen and LPS enhanced antigen uptake and the subsequent 
processing of the antigen acquired for both MHC class I and class II peptide 
presentation [68]. Thus, DC have the capacity to perform a whole set of complex 
functions immediatly after TLR activation. It was later shown by Blander et al. that the 
presence of TLR ligands in the phagosome affects phagosome maturation and 
subsequent antigen processing and presentation [69, 70].  Of note, however, this finding 
has been the subject of debate [71-74]. It is reasonable to suggest that from an 
immunological perspective it would be beneficial if TLR signalling from the 
phagosome would affect the maturation of the phagosome, and thus the subsequent 
antigen processing and presentation. In particularly, since antigen uptake by DC can be 
quite unspecific [68] (paper III). Moreover, it is clear that phagosomes are cellular 
compartments from where TLR signalling also occure. Interestingly, data published 
earlier this year suggest that TLR signalling from phagosomes can lead to the 
recruitment of mitochondria via TRAF6 and the subsequent induction of mitochondrial 
reactive oxygen species (mROS) production, which increase the intraphagosomal 
killing of the bacterium Salmonella typhimurium [75]. Collectively, these findings 
further solidify the notion that intraphagosomal TLR activation might affect the 
maturation and function of the phagosome. 
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Endocytic processes in dendritic cells 
 
As mentioned earlier, the capacity of DC to ingest extracellular material is key for 
efficient intracellular antigen processing, the loading of antigens onto MHC molecules, 
and presentation to T cells. Dendritic cells use different endocytic pathways for antigen 
uptake, i.e., phagocytosis, macropinocytosis, and receptor-mediated endocytosis. 
Phagocytosis and macropinocytosis are two distinct endocytic processes, which are 
utilized by DC to ingest various antigens [76, 77]. In general, DC internalize small 
soluble extracellular antigens via macropinocytosis, including viruses, proteins, and 
fragments from bacteria and apoptotic cells [78-82], whereas the uptake of particulate 
material larger than 0.5 µm occurs via phagocytosis [76] (Figure 3).  
 
 
Figure 3. Schematic figure showing antigen uptake via macropinocytis and phagocytosis. 
 
Macropinosomes form as a result of plasma membrane ruffles that curve into open cups 
that then close and fuse, thereby trapping extracellular material [77, 83].  Thus, 
macropinocytosis proceeds independently of the material ingested particles. In contrast, 
phagosome formation is initiated and shaped by the particles they ingest [77]. At the 
molecular level, signalling in phagocytosis is localized in well defined short-range and 
medium-range membrane regions close to the particles that are internalized, whereas 
signalling for the regulation of macropinocytosis seems to be distributed more 
randomly [77]. Furthermore, phagocytosis can be subdivided into three distinct 
subtypes, i.e., “zipper phagocytosis”, “triggered phagocytosis”, and “sinking 
phagocytosis”. Despite the different spatial requisites for inducing signals that regulate 
the processes of macropinocytosis and phagocytosis, they share common signalling 
pathways, all of which are affected by TLR signalling [84]. 
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DC migration from peripheral tissues 
 
Toll-like receptor signalling initiates a process of morphological and functional 
maturation, leading to changes in the chemokine receptor profile that initiate migration 
from peripheral tissues towards the draining lymph nodes, where the DC activate the 
adaptive arm of the immune system [61, 85, 86]. During maturation, DC upregulate the 
chemokine receptor CCR7, in turn making them responsive to CCL19 and CCL21, 
which drives their migration to the draining lymph node T cell areas where antigens are 
presented to T cells [87-90]. Complementary roles in DC migration have also been 
suggested for CCR8-CCL1, CXCR4-CXCL12, and S1P-S1P1/3 [91-93]. However, 
CCR7 seem to be most pivotal [94]. In the absence of CCR7 DC fail to reach the lymph 
nodes, and DC in the spleen remain located in the marginal zone outside of the white 
pulp and T cell areas [95, 96]. Exactly how DC execute this complex journey from 
peripheral tissues to the T cell areas of lymph nodes is not fully understood. It has been 
shown that endothelial cells of lymph vessels upregulate adhesion molecules, e.g., 
ICAM-1 and VCAM-1, E-selectin, and chemokines, e.g., CCL5, CCL20, and CXCL5, 
in response to cytokine stimulation [97]. Moreover, it was shown that neutralizing 
antibodies to ICAM-1 and VCAM-1 hindered DC adhesion to and migration through 
the endothelium of lymph vessels both in vitro and in vivo [97]. A long these lines, it 
was also shown that mice deficient in ICAM-1 have impaired trafficking of Langerhans 
cells to the draining lymph nodes [98]. In contrast, earlier data by Erdmann et al. 
suggests that Langerhans cell migration into lymph nodes is not impaired in mice 
deficient in selectin ligands [99]. Moreover, it was recently been shown that DC 
deficient in all integrin heterodimers migrate to the lymph node in an unimpaired 
manner [100]. Thus, it is believed that DC can migrate from peripheral tissues into 
lymph nodes independently of integrins [31], suggesting that more of an amoeboid type 
of migration is utilized [100, 101]. An important feature of cellular movement and 
navigation through dense tissues is the capacity to degrade extracellular matrix. It has 
been speculated that specialized cellular protrusions, the so-called podosomes are of 
importance in this process. Podosomes are highly dynamic, large actin dense adhesion 
structures (Figure 4) that are found in a variety of cell types, such as osteoclasts, 
macrophages, and DC, all of which needs to degrade extracellular matrixes [102, 103]. 
In Rous sarcoma virus transformed cells, where podosomes were first described, the 
podosomes were found on the ventral surface [104-106]. Podosomes have since then 
been linked to different functions such as resorbtion of bone and trans-cellular 
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migration [107, 108]. Osteoclasts use their podosomes, for bone degradation [107, 
109]. In DC, however, podosomes thought to be used to enable migration through 
dense tissues [110]. This process involves matrix metalloproteinases (MMP), which are 
concentrated at the podosomes in order to degrade the connective tissue matrix [110-
112]. It has been suggested that podosomes act as pathfinders in DC and enable 
degradation of the extracellular matrix at the front of the moving cell to facilitate 
movement in dense connective tissues [110]. 
 
 
 
Figure 4. (A) Confocal microscopy picture of phalloidin-stained podosomes. (B) Transmission electron-
microscopy (TEM) high-resolution picture of a single pososomes. (C) Schematic figure of the actin 
cytoskeleton and some of the actin associated proteins, involved in the podosme structure.    
 
On their way to the lymph nodes DC process the antigens acquired for peptide loading 
onto MHC class I and class II molecules and for the subsequent presentation to CD8+ 
and CD4+ T cells, respectively [16, 19, 113]. The ingested antigen is degraded and 
either loaded onto MHC class II molecules in specialized lysosomal compartments 
[114-117], or can be transferred into the MHC class I presentation pathway through a 
process referred to as cross-presentation [78, 118, 119]. The MHC class I molecules are 
synthesized de novo and, after peptide loading in the endoplasmic reticulum, MHC-
I/peptide complexes are transported to the cell membrane. In contrast, newly 
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synthesized MHC class II molecules are transported to endolysosomal compartments 
where the peptides are loaded, followed by the transportation to the cell membrane. 
Toll-like receptor stimulation increases the efficiency of antigen processing and 
presentation for both the MHC class I and class II presentation pathways. Upon TLR 
activation both class I and class II molecules are stabilized on the cell surface, whereas 
in the absence of TLR activation MHC/peptide complexes are rapidly internalized and 
degraded [65, 120-122]. Furthermore, the generation of peptides for MHC class I and 
class II presentation is further enhanced by altered proteasome activity and lysosomal 
processing capacity, respectively [123-125]. On their way to the lymph nodes, TLR-
activated DC also starts to upregulate co-stimulatory molecules including CD80 and 
CD86, which are important for the activation of naïve T cells [126]. Toll-like receptor 
activation also triggers the induction of the co-stimulatory molecule, CD40, on DC, 
which interacts with CD40L on helper T cells.  The CD40-CD40L interaction leads to 
the further upregulation of co-stimulatory molecules and the production of cytokines by 
DC, which are key for the induction of adaptive immunity [61, 127]. Thus, when DC 
arrive in the lymph node they are ready for the activation of T cells. 
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INTRODUCTION TO THE WORK IN THIS THESIS  
 
In order to give an overview of the work I undertook for my thesis, in this section I 
will present the studies included. My thesis is composed of three studies that focused 
on different aspects of DC activation and the consequent downstream effects of such 
activation. Briefly, in paper I, the effect of low physiological temperature on key DC 
functions associated with both innate and adaptive immunity, was explored. In paper 
II, podosome formation and function in DC derived from mice lacking the actin-
severing and capping protein gelsolin, were analysed. In paper III, the effect of 
soluble TLR ligands, such as LPS, on the phagocytic capacity of DC, was 
investigated. In the following sections, I will start with an overview of the three 
papers included in the thesis, and explain the rationale and relevance of these 
projects. Then, the results will be presented and discussed in relation to existing 
literature in this field of research. Finally, I will describe the materials and methods 
used in these studies. For detailed descriptions of the studies on which my thesis is 
based, please read the papers that are included as appendices at the end of the thesis. 
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BACKGROUND TO THE PAPERS 
 
Dendritic cells are widely distributed throughout most tissues and have important 
functions in both immunity and tolerance; they are also considered candidate targets in 
new immunotherapy protocols [128]. However, DC in different locations of the body 
operate under various conditions and the route of administration of a DC-based 
vaccination is often via intra-dermal or subcutaneous injections in sites that have 
significantly lower temperatures than the core temperature. In the skin, the temperature 
can be as low as 26°C at the extremities at an ambient temperature of 20°C [129-131]. 
This fact is often ignored and most studies on DC biology so far have only been 
performed at 37°C or at fever-range temperatures [132-135]. To the best of our 
knowledge, no studies have thus far examined how low physiological temperatures 
affect DC antigen handling and immune stimulatory capacities. This prompted us to 
examine some key DC functions at a low physiological temperature of 28°C (paper I). 
Although we found that several DC functions are intact at this low temperature, we also 
found that several functions were affected by low physiological temperature. This 
includes NO production, podosome activity, and the capacity of DC, activated at 28°C, 
to elicit T cell proliferation. We observed that several DC functions were slightly 
delayed but otherwise they were relatively unaffected by low physiological 
temperatures, whereas other functions important for activation of the adaptive 
immunity were impaired. Collectively, our study demonstrates that temperature 
changes within the physiological range have the capacity to modulate DC functions.  
 
In order to activate T cells in the lymph nodes, DC migrate from peripheral tissues to 
the T cell areas of the draining lymph nodes. It is believed that podosomes facilitate 
migration through dense tissues and enable cells to penetrate barriers such as basement 
membranes and the endothelium [111]. However, their exact function in DC remains 
elusive. Several proteins involved in actin cytoskeleton remodelling have been 
suggested to be important for podosome dynamics and function [107, 136-140]. Since 
it was shown that the actin-severing and capping protein gelsolin is key for podosome 
formation and function in osteoclasts [107], gelsolin is commonly mentioned in the 
literature as an essential protein for podosome function [141-146]. Furthermore, in a 
paper by Hu and colleagues, a theoretical model for the regulation of podosome 
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dynamics that is dependent on the severing of actin filaments by gelsolin was presented 
[146]. Gelsolin was found to localize to podosomes already in the early studies of these 
structures, and gelsolin was also found in podosomes expressed by DC [110, 147]. 
However, it was reported that functions dependent on actin cytoskeleton rearrangement 
in DC seem to be independent of gelsolin [148]. This paper also reported that 
“podosome-like” structures were present in DC lacking gelsolin, but these structures 
were however not further investigated. Therefore, we investigated whether or not 
functional podosomes form in gelsolin-deficient DC. The actin-rich structures observed 
by West et al. [148], were indeed confirmed to be podosomes. Furthermore, we show 
that the dynamics and functions of the podosomes in DC are regulated independently of 
gelsolin.   
 
Phagocytosis is an important function of DC for sampling antigens for subsequent 
antigen presentation to T cells. Upon the recognition of microbial danger products by 
TLR the cytoskeleton of DC rapidly starts to reorganize, leading to the dissolution of 
podosomes, increased ruffling, and increased uptake of extracellular bulk fluids via 
macropinocytosis [68]. The studies of the effects of TLR activation on phagocytosis, 
however, show somewhat contradictory results. It was shown that macrophages 
phagocytosed TLR4 ligand–expressing Neisseria meningitidis in an TLR4 independent 
manner [149]. Moreover, phagocytic uptake of TLR2-stimulating Zymosan proceeded 
normally in TLR2- or MyD88-deficient macrophages [150]. In contrast, when 
RAW264.7 cells were stimulated with LPS, for 24h before adding Escherichia coli, the 
phagocytic uptake was stimulated in a TLR4-dependent but MyD88-independent 
manner [151]. A long these lines, it was shown that TLR ligands stimulate the 
phagocytic uptake of E. coli and Staphylococcus aureus, while having negligible 
effects on the phagocytic uptake of latex beads [152, 153]. Although, many studies 
have been performed to explore the consequences of TLR activation and phagocytosis, 
these studies were all carried out after several hours of pre-activation. Thus, these 
studies mainly reflect the results of the induction of gene programmes and the 
subsequent synthesis of proteins involved in phagocytosis, e.g., upregulation of 
phagocytic receptors, rather than the immediate consequences of pathogen recognition. 
However, the process of phagocytosis is likely to be influenced within minutes of TLR 
ligation and an immediate increase in antigen uptake might be beneficial to the host 
both in terms of limiting the infection as well as in boosting antigen processing and 
presentation. In the case of bacterial infection, the active portion of TLR2 binding 
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lipoprotein when anchored in the bacterial membrane, remain unreachable for the 
ligation to TLR2 and, similarly, the TLR4-binding portion of LPS, i.e., lipid A, is 
integrated in the lipid bi-layer of Gram-negative bacteria, remaining inaccessible for 
TLR4 ligation. Consequently, lipoprotein and LPS ligation to the respective TLR most 
likely occurs when released due to disruption of the bacterial membrane. Thus, it may 
be of relevance to examine TLR ligation with soluble TLR ligands. Herein we study 
how soluble TLR ligands affect the phagocytic machinery in DC, proximal to gene 
transcription. 
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PRESENTATION OF THE PAPERS 
 
Paper I: DC function at low physiological temperatures 
 
The temperature of the body is tightly regulated. It is known that an increased body 
temperature modulates a wide array of immune functions. However, how physiological 
temperatures below the core temperature affect cells of the immune system remains 
unclear. In order to investigate whether or not a low physiological temperature affects 
the innate functions of DC we started by examining the capacity of DC to respond to 
TLR activation. Although we observed a delay in activation of the ERK and p38 
MAPK pathways downstream of TLR activation at 28°C compared to 37°C, the DC 
also responded to TLR stimulation at 28°C. Therefore, we investigated whether or not 
cellular processes, which are dependent on TLR signalling, were affected by delayed 
phosphorylation and activation. The results showed a delayed, but not impaired, TNF 
secretion and macropinocytic uptake in response to TLR stimulation. Our cytokine data 
are along the lines of some previous studies, which showed that temperature modulates 
cytokine production and secretion in different cell types [154]. However, published 
data on cytokine secretion are somewhat contradictory, where some studies showed 
increased cytokine production whereas others showed decreased cytokine production. 
For example, Yan et al. showed that a temperature within the fever-range (39.5°C) 
promoted TLR4 expression and MAPK signalling in DC leading to the increased 
production of IL-6, IL-10, and IL-12 [155]. In contrast, studies by Hagiwara et al. on 
RAW264-7 cells, suggested that the cytokine release of HMGB1, IL-1!, IL-6, and TNF 
was reduced following LPS stimulation at 40°C and 34°C compared to 37°C [156]. In 
study by Kirkley et al., who also used RAW264-7 cells, it was shown that TNF 
secretion was increased at 31°C compared to 37°C, while TNF secretion was decreased 
at 39°C. However, in the same study, IL-6 secretion was decreased at 31°C compared 
to 37°C and remained unchanged at 39°C. Moreover, the authors showed that IL-10 
secretion was decreased on either side of 37°C, thus suggesting that temperature 
alterations might have different effects on cytokine secretion [157]. In addition, it was 
also shown that fever-range thermal conditions differentially regulate the cytokine 
production in immature or mature murine bone marrow-derived DC, suggesting that 
fever might have a direct regulatory capacity on DC [135]. In the present study, we 
observed a delayed TNF production but the levels of secreted TNF were similar to 
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those cells kept at 37°C, 8 hours after LPS activation. If cytokine secretion in our study 
had been measured only at one time point, i.e., at 4 h, 8 h, or at 18 h after TLR 
activation, the interpretation of the results would have been quite different depending 
on which time point was analysed (Figure 5) This may explain the varying results in the 
abovementioned studies, and it stresses the importance of performing adequate kinetic 
measurements.  
 
 
 
Figure 5. Adapted from Figure 3, paper I. Kinetics of TNF production after TLR activation at 28°C and 
37°C. 
 
Next, the capacity of DC to ingest antigens via phagocytosis and macropinocytosis was 
assessed at 28°C and 37°C. We found that phagocytosis of opsonized sheep red blood 
cells (SRBC) by DC was unaffected at 28°C compared to phagocytosis at 37°C. 
Moreover, although delayed, the TLR stimulated dextran uptake via macropinocytosis 
reached similar levels at 28°C and 37°C. However, the total amount of material 
ingested by the DC did not appear to decrease at the lower physiological temperature. 
The results of studies on how different physiological temperatures affect antigen uptake 
via phagocytosis are similar to the results of studies on cytokine secretion also 
somewhat contradictory. On the one hand it was shown that murine peritoneal 
macrophages increase their phagocytic uptake by 40% when incubated at 39°C 
compare to when kept at 37°C; and on the other hand, when incubated at 41°C the 
levels of uptake decreased [158, 159]. Collectively, this suggests that even small 
differences in temperature could have significant effects on phagocytosis. In contrast to 
this, Utoh and Harasaki observed no significant alterations in the phagocytosis of 
opsonized latex beads by human neutrophils of were to be found in the range of 25-
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42°C [160]. We found that antigen uptake is unaffected by low physiological 
temperature. This might appear to be rather surprising from a biochemical point of 
view, since membrane fluidity could be affected by a decrease in temperature. 
However, from an immunological perspective, our results might be less surprising since 
28°C is a common temperature in parts of the skin, thus, if the endocytic capacity was 
compromised at this temperature one could envisage that subsequent functions of DC, 
important in the induction of adaptive immunity, would be impaired.  
 
Dendritic cells produce NO during the early defense against pathogens after TLR 
activation [161, 162]. If low physiological temperatures affects NO production remain 
unclear. Interestingly, we observed that production of the NO metabolite nitrite after 
TLR stimulation was severely impaired at 28°C (Figure 6). One could speculate that 
lower temperature might modulate and hinder NO production in order to ensure 
appropriate immune activation.  
 
 
 
Figure 6. Adapted from Figure 3, paper I. NO production after the indicated time points at 28°C or 37°C, 
LPS treated and untreated. 
 
The migration and homing of lymphocytes and DC to lymphoid organs are key for the 
induction of immunity and tolerance. Fever-range temperatures have been shown to 
increase the homing of circulating lymphocytes to lymph nodes by increasing L-
selectin-dependent adhesive interactions between lymphocytes and high endothelial 
venules (HEV) [163, 164]. Chen and colleagues recently showed that fever-range 
temperatures increase the display of intercellular adhesions molecule 1 (ICAM-1) and 
  19 
CCL21 specifically in HEV. This suggests that HEV are sensitive to thermal changes 
and that increase in temperature intensifies immune surveillance by increasing 
lymphocyte trafficking to lymphoid organs during inflammation [165]. A long these 
lines, it was also shown that DC migration, similar to lymphocyte migration, is 
stimulated by fever-range hyperthermia [132]. Hence, it is not surprising that treatment 
at fever-range temperature enhances both humoral and cellular immune response [164, 
166]. Although, it has been show that hypothermia leads to a decrease in lymphocyte 
circulation [167], no studies have to my knowledge addressed the effects of low 
physiological temperature on DC. It has, however, been shown that neutrophils display 
a significant impairment of migration at 29°C in vitro [168]. We observed that 28°C did 
not affect DC migration through uncoated transwell filters and podosome formation 
was not affected. However, we also found that the capacity of podosomes to degrade 
the matrix and the ability of DC to migrate through Matrigel-coated transwell-
membranes were impaired at 28°C compared to at 37°C. These data suggest that an 
increase in temperature in peripheral tissues, as a consequence of inflammation, might 
enhance the ability of DC to migrate to lymphoid organs.  
 
We next examined the effect of 28°C on the antigen uptake and processing capacity of 
DC by studying the presentation of the HEL (46-61) epitope on H-2 I-Ak using the 
specific antibody C3H4 [169]. We found no inhibitory effect of low temperature on the 
generation of I-Ak/HEL (46-61) complexes in unstimulated DC, suggesting that steady-
state antigen processing and presentation, which are important for the maintenance of 
peripheral tolerance [2]. A consistent trend of higher generation of the HEL (46-61) 
epitope was, however, observed at 37°C after LPS stimulation in five experiments, 
although this trend did not reach statistical significance (p>0.05). When studying the 
surface molecule expression of co-stimulatory molecules, we observed that the 
upregulation of CD40 was reduced when the DC were activated and incubated at 28°C, 
but that this upregulation was rescued when the DC were moved to 37°C after 4 h of 
activation at 28°C. This experimental setup was used to mimic the local increase in 
temperature during inflammation, or when DC migrates to deeper tissues with a higher 
temperature, i.e., from the skin to draining lymph nodes. Because the CD40-CD40L 
interaction is important in the activation of naïve T cells, the lack of upregulation of 
CD40 at a low temperature could prevent inappropriate naïve T-cell activation by DC 
in the skin.  
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These temperature shift experiments imply that the inhibitory effect of low temperature 
can be reversed if the temperature is increased. However, the capacity of DC that had 
taken up antigens and been activated by TLR at 28°C and then shifted to 37°C after 4 
hours to activate T cells was decreased. This observation was also confirmed using an 
allogenic setting, suggesting that temperature modulations of the ability of DC to 
activate T cells are not only dependent on antigen processing and presentation. Thus, 
other factors important for the T cell-stimulatory function of activated DC are 
suppressed when DC are activated at 28°C. The proliferation of T cells has been shown 
to be sensitive to lower 29-33°C temperatures, however, effector cytolytic activity of T 
cells is markedly insensitive to temperature changes. Hence, it has been speculated that 
fever or local tissue inflammation might act to temporarily ablate the cooler portions of 
normal thermal gradients, thereby selectively amplifying the emergence of T cell 
immunity in peripheral tissues [170]. Collectively, our results suggest that differences 
in temperature need to be taken into account when developing immunotherapeutic 
strategies that target DC at different locations. In particular, DC that have taken up 
antigens and been activated at 28°C have an impaired ability to activate T cells. 
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Paper II: Gelsolin-independent podosome formation in DC  
 
The actin-severing and capping protein gelsolin is an actin-cytoskeleton-regulating 
protein that has been reported to localize to podosomes in several cell types. It has also 
been reported to be important for the formation and function of podosomes in osteclasts 
[107, 147]. Moreover, in a paper by Hu et al., a theoretical model for podosome 
regulation was postulated in which gelsolin played a central role [146]. Thus, gelsolin 
is often mentioned in the literature as an essential protein for podosome formation [143, 
144, 171-174]. In a previous paper by West et al. podosome-like structures were 
observed in gelsolin-deficient DC; however, these structures were not characterized 
[148]. Thus, we decided to study these podosome-like structures in DC in order to 
clarify whether or not they were indeed podosomes and, if so, whether or not they were 
functional. In contrast to what was previously shown in osteoclasts, we concluded in 
paper II that gelsolin is dispensable for podosome formation and function in DC, 
suggesting that podosomes are differentially regulated in DC and osteoclasts.  
 
In the paper by West et al. actin was stained using phalloidin in gelsolin-deficient DC 
and showed structures that resembled podosomes [148]. We confirmed that these 
structures were indeed podosomes by using an antibody specific for the podosome-
associated protein vinculin [173]. The number of cells presenting podosome structures 
was quantified and no difference was found between gelsolin-deficient and wild-type 
DC. Furthermore, the podosomes were visualized using transmission electron 
microscopy (TEM). The podosomes were clearly identifiable in both the wild-type and 
the gelsolin-deficient DC. After having established that the formation of podosomes in 
DC is independent of gelsolin, we continued these studies by investigating the 
dynamics of podosome assembly and disassembly in gelsolin-deficient DC. Dendritic 
cells were transduced using a retroviral vector coding for GFP-actin, after which the 
cells were studied using live-cell imaging. The quantitative analysis of the life-time of 
podosomes in DC revealed that the dynamics of podosome assembly and disassembly 
in DC are unaffected by a lack of gelsolin. In DC, it was shown that podosomes are 
negatively regulated by signalling downstream of TLR. Hence, the activation of DC 
with soluble TLR ligands leads to a rapid and transient disassembly of podosomes and 
the concomitant loss of migratory capacity [68, 112]. One could speculate that this 
transient halt in migration might serve to prevent DC from migrating from the site of 
infection for a short period and to focus them on acquiring antigens via 
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macropinocytosis and/or phagocytosis, which are boosted upon TRL activation [68] 
(paper III), (Figure 7). 
 
 
 
Figure 7. Adapted and modified from West et al. [68]. Transient boost in macropinocytic uptake after 
LPS stimulation and concomitant podosome disassembly. 
 
Podosome dynamics were further studied by the quantifying the percentage of wild-
type and gelsolin-deficient DC that exhibited podosomes after LPS stimulation. The 
cells were stimulated for 20 min, as this is the peak time-point when most cells present 
no podosomes. No difference in podosome disassembly was found in the presence or 
absence of gelsolin. Thus, the actin severing activity of gelsolin is dispensable in 
podosome disassembly induced by TLR signalling.  
 
Finally, the functionality of podosomes in the absence of gelsolin was investigated. In 
order to address this, the capacity of DC to degrade extracellular matrix was quantified. 
Glass cover-slips were coated with Oregon-green gelatin, after which DC were seeded 
on top and incubated over night before analysis. Fluorescence microscopy was used to 
quantitatively analyse the total area of degraded gelatin (Figure 8).  
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Figure 8. a) Actin stained with phalloidin, b) Oregon-green gelatin, c) nuclei stained with dapi, d) over-
laying picture showing how the DC have degraded an area of gelatin. The area of degraded gelatin could 
then be measured and quantified.   
 
Gelsolin-deficient DC were found to be able to degrade the gelatin as efficiently as 
wild-type DC. In paper I, we showed that the migration of DC migration in a transwell 
system correlates well with the matrix degrading activity of their podosomes. To 
further investigate the functionality of DC deficient in gelsolin, we asked whether or 
not gelsolin is required for this capacity to degrade extracellular matrix in order to 
migrate through dense tissue matrixes. In order to address this, a transwell migration 
assay, where the membranes were coated with a dense layer of Matrigel, was used. We 
found that gelsolin-deficient DC and wild-type DC migrate equally well from the upper 
chamber with the Matrigel-coated membrane to the lower chamber.  
 
In conclusion, the actin-severing and capping protein gelsolin is dispensable for 
podosome formation, dynamics, and function in DC. Our data suggest that podosomes 
in different cell types may be differentially regulated. It is possible that rather than 
being one structure found in many cell types, as described in the current literature, 
podosomes could actually be a family of structures with many similarities but also 
many differences. Thus, the data obtained on podosomes from experiments on one cell 
type may not necessarily apply for podosomes in all other cell types.  
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Paper III: Toll-like receptor stimulated phagocytosis in dendritic cells 
 
It has previously been shown that TLR activation with soluble LPS leads to a rapid and 
transient increase in the capacity of DC to ingest extracellular fluids via 
macropinocytosis [68]. Whether or not the stimulation of DC using soluble TLR 
ligands also affects the uptake of particulate material via phagocytosis has not yet been 
shown. The studies on TLR and their role in phagocytosis have so far examined 
whether or not TLR ligands affect the phagocytic capacity post protein synthesis, i.e., 
several hours after pathogen recognition. It is possible that when a pathogen is to be 
ingested, it would be favourable for the host cell to increase its phagocytic activity 
immediately after pathogen recognition. However, most studies on TLR activation and 
phagocytosis have studied phagosome maturation or phagocytic capacity after a period 
of 12 to 24 h post-TLR activation [69, 70, 73, 149-153]. 
 
It is well known that many of the molecules involved in cytoskeletal reorganization are 
activated upon TLR activation. More recently, a quantitative examination of the 
macrophage phosphoproteome also showed profound global changes in the 
phosphoregulation in cells downstream of TLR activation [84, 175]. In a study by 
Weintz et al., 1850 phosphoproteins with 6956 phosphorylation sites were identified. It 
was shown that TLR activation caused major dynamic changes in the 
phosphoproteome, with about 24% being upregulated and 9% being downregulated, 
identifying the cytoskeleton as a major hotspot of LPS regulated phosphorylation [84]. 
These studies further solidify previous speculations that TLR activation could affect the 
processes of phagocytosis [176-178]. 
 
In order to investigate whether or not TLR engagement could affect phagocytosis in 
DC, the phagocytic capacity of DC stimulated with the TLR4 agonist LPS for 30 min 
was studied. We found that LPS stimulation results in a significant transient increase in 
DC that ingests polystyrene beads shortly after activation. In order to confirm that the 
beads associated with DC were indeed internalized, the actin polymerization inhibitor 
cytochalasin D was used, and showed that the association with three or more beads 
represents a reliable measure of internalization; therefore, three beads were therefore 
set as a cut-off level for phagocytosis in the following experiments. Moreover, the 
inhibitor dimethyl amelioride (DMA), which specifically blocks macropinocytosis 
[179], was used to exclude the possibility that the beads were taken up via 
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macorpinocytoisis and not phagocytosis. Similar results to those found in previous 
studies [180, 181], were obtained, where the uptake of dextran was markedly decreased 
in the presence of DMA whereas the uptake of beads was not affected, demonstrating 
the functionality of DMA. Thus, we concluded that the LPS-stimulated uptake of 
polystyrene beads by DC was indeed mediated via phagocytosis. Internalization of the 
beads was further confirmed using immunofluorescence microscopy (Figure 9). We 
also confirmed that the stimulation of DC with LPS for 20 minutes, results in uptake of 
significantly more beads. We, thus, conclude that stimulation of DC with LPS leads to 
enhanced phagocytic uptake of 1 µm polystyrene beads early (20-30 min) on after 
stimulation.  
 
 
 
Figure 9. Adapted from Figure 1, paper III. Microscopy analysis of the capacity of DC to phagocytose 
polystyrene beads. A, Immunofluorescence images of Alexa 647-stained untreated or LPS-activated DC 
that had phagocytosed polystyrene beads. B, Quantification of the numbers of beads ingested by 
untreated (open bars) or LPS-treated (black bars) DC.  
 
Next, we studied whether also other TLR ligands could stimulate phagocytosis. Indeed, 
all four TLR ligands studied, TLR1/2, TLR4, TLR6/2, and TLR9 ligands, were all 
capable of inducing increased phagocytic uptake in DC. Since LPS was the most 
effective stimulus for inducing enhanced phagocytosis, all subsequent assays were 
performed using LPS as the model TLR ligand. Next, we studied the kinetics of LPS-
stimulated phagocytosis in DC. When studying the kinetics of phagocytosis, we found 
that the stimulation of DC was rapid; 10 min after LPS stimulation a significant 
increase in phagocytosis was observed. This suggests that the rapid and transient boost 
in phagocytic capacity most likely precedes gene transcription. This was confirmed by 
studying phagocytic uptake in the presence of actinomycin D, which blocks gene 
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transcription [182]. Thus, we concluded that the TLR-stimulated boost in phagocytic 
uptake precedes the effects of gene transcription.  
 
The ligation of TLR4 results in a trans-membrane signalling transduction, which 
activates intracellular signalling via TIRAP-MyD88-dependent and TRAM-TRIF-
dependent pathways [183, 184]. It has previously been shown that TLR4 activation has 
the capacity to regulate gene programmes involved in phagocytosis, independently of 
MyD88 [151]. However, since TLR4 signalling downstream of both MyD88 and TRIF 
is complex and to some extent overlaps, studies on MyD88-deficient cells alone, such 
as those of Kong et al. [151], may not reveal alterations in the process of phagocytosis 
of pathogens expressing TLR4 ligands. Hence, the participation of TLR4, MyD88, and 
TRIF on the LPS-stimulated phagocytosis were investigated using mice deficient in 
either MyD88 or TRIF, as well as in a mouse strain deficient in both MyD88 and TRIF, 
i.e., a “double knock-out” mice. First, we confirmed that the LPS-stimulated uptake 
only depended on TLR4 by studying the uptake in DC derived from mice deficient in 
TLR4. Next, we observed that in DC deficient in MyD88 or TRIF the stimulation of 
phagocytosis was only partially decreased, while in DC deficient in both MyD88 and 
TRIF the stimulation of phagocytic uptake was completely ablated. Thus, TLR4 
signalling through both adaptor molecules, MyD88 and TRIF, was required for the 
optimal stimulation of phagocytosis proximal of protein synthesis.  
 
In order to address whether or not TLR activation could boost the phagocytic uptake of 
larger and, to some extent, more physiological substrates, we used SRBC labelled with 
PKH26 or apoptotic cells labelled with CFSE. Of note, all extracellular SRBC were 
removed by lysis before analysis to ensure that only internalized SRBC were counted. 
The number of DC that phagocytosed SRBC upon LPS stimulation was significantly 
increased. A long these lines, we observed that TLR4-stimulated DC more efficiently 
phagocytosed apoptotic A20 cells. Thus, TLR4 activation has the capacity to augment 
the phagocytic uptake of cellular substrates. The target substrates studied above all 
share the common feature of being relatively weak inducers of phagocytosis, although 
one could argue that apoptotic cells trigger phagocytosis comparatively well. In order 
to examine whether or not TLR activation also has the capacity to stimulate the uptake 
of opsonized particles, which are potent inducers of phagocytosis, we used anti-SRBC 
antisera. We found that the effect of stimulating phagocytic uptake with TLR4 
activation, as seen when studying the non-opsonized SRBC, decreased with increasing 
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concentrations of anti-SRBC antisera, suggesting that the TLR stimulation of 
phagocytosis is more prominent when the target substrates are poor inducers of 
phagocytosis. Similarly, it was previously shown that LPS is unable to augment the 
phagocytic uptake of particles opsonized with IgG [185]. Thus, considering all of the 
above, it is reasonable to suggest that TLR signalling does not further increase Fc-
receptor-mediated phagocytosis. In summary, we provide evidence to show that soluble 
TLR ligands have the capacity to rapidly boost the phagocytosis process in DC, 
proximal to gene transcription. 
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MATERIALS AND METHODS 
 
A brief description of the methods used in these studies is provided below. For a more 
detailed description, please see the “Materials and methods” section in each of the 
papers included in the thesis. 
 
Mice and bone marrow–derived DC 
 
In these studies, we chose to use DC derived from murine bone marrow using the GM-
CSF, initially described by Inaba et al. [32]. This pivotal discovery provided a robust 
experimental system that has been of tremendous importance for the studies of DC 
biology. Furthermore, this system has the advantage of generating large numbers of 
DC, beneficial for the experimental setup used in our studies. In addition, it is still the 
most frequently used technique for generating primary DC, thus, enabling us to readily 
compare the data obtained to data from other studies within this field. More recently, it 
was been shown that the DC derived using this system seem to be equivalent to certain 
DC that emerge in vivo, in particular those that emerge upon inflammation [186]. 
Retrospectively, the Flt3-ligand-derived DC could also have been used for these studies 
as the DC derived using the Flt3-ligand might better represent the DC found at steady-
state; however, these cell cultures are less homogenous and give rise to two DC 
subsets: CD24lowCD11bhigh and CD24highCD11blow [186].  
 
The mice used were six to ten weeks old, breed and housed under specific pathogen-
free conditions. In paper I, C57BL/6 (B6) and C3H/hen mice, were used and housed at 
the Department of Microbiology Tumour Biology and Cell Biology Animal Facility, 
Karolinska Institutet. In paper II, B6 and gelsolin knock-out mice with a B6 
background were housed in the animal facility at the Translational Medicine Division, 
Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School or 
at the Institute of Genetics, University of Bonn. In paper III, B6 and B6.TLR4-/-, 
B6.MyD88-/-, B6.TRIF-/-, and B6.MyD88-/-TRIF-/- mice were bred and housed at the 
Department of Microbiology, Tumour Biology, and Cell Biology Animal Facility, 
Karolinska Institutet or at the Immunobiology Laboratory, London Research Institute, 
Lincoln’s Inn Fields Laboratories, London. The DC were generated from murine bone 
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marrow from femur and tibia as previously described [32], and also described in the 
papers.  
 
Analysis of TNF and NO secretion (paper I) 
 
In paper I, the capacity of DC to secrete TNF and NO in response to LPS stimulation 
at 28°C and 37°C was evaluated using and enzyme linked immunosorbent assay 
(ELISA) and Griess assay, respectively.  
 
Internalization assays (paper I and paper III) 
 
In both papers I and III, we studied the uptake of particles, including polystyrene 
beads and SRBC, via phagocytosis and the uptake of fluorescein isothiocyanate 
(FITC)-dextran via macropinocytosis. The TLR4 ligand LPS was used throughout 
paper I as the model TLR ligand, whereas, in paper III, other TLR ligands other than 
LPS (TLR1/2, TLR2/6 and TLR9) were also used. In order to study phagocytosis, after 
the DC were stimulated with TLR ligands, 1 µm yellow/green fluorescent polystyrene 
beads were added to each well at a bead to DC ratio of 40-50:1 and incubated for 30 
minutes. For the studies on macropinocytosis, 70-kDa FITC-dextran was used and 
added to the cells for 20 minutes. The uptake of FITC-dextran is commonly used to 
investigate uptake via macropinocytosis [187-189]. The cells were washed before 
staining on ice with anti-CD11c mAb, followed by an additional washing step. 
Polystyrene bead uptake by the DC was quantified by flow cytometry using a 
FACSCalibur cytometer and CellQuest software. In paper III a variety of compounds 
that inhibit various molecular processes were used to determine the phagocytic uptake 
process. Moreover, dimethylamelioride was used to inhibit macropinocytosis, 
specifically. The inhibitors were added to the cells 30 minutes before TLR stimulation. 
 
To study the phagocytic uptake of cells we used non-opsonized or opsonized SRBC or 
apoptotic cells. The SRBC were stained using PKH-27; and for opsonization the SRBC 
were incubated with an anti-SRBC antisera. The DC were harvested and transferred to 
a 96-well plate as described above. The SRBC were added to the DC at an SRBC to 
DC ratio of 20-30:1 and incubated for 30-45 min, after which the cells were spun down 
and any extracellular SRBC were lysed with RBC lysis buffer. The cells were then 
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washed twice before staining with anti-CD11c mAb and incubated on ice, after which 
the cells were washed extensively. Phagocytosis was quantified using flow-cytometry 
as described above. In order to study the uptake of apoptotic cells, the A20 cell line, an 
Fas apoptosis sensitive B cell lymphoma [190, 191], was used. These cells were first 
stained with CFSE after which FasL mAb was added to the cells to induce apoptosis. 
The cells were incubated for 8 h, washed twice, added to the DC at a apoptotic cell to 
DC ratio of 20:1 and incubated for 30-45 min. The DC were then stained, washed and 
analysed by flow cytometry, as described above.  
 
Immunofluorescence microscopy analysis of phagocytosis (paper III) 
 
For the immunofluorescence microscopy, DC were processed in a similar way to the 
bead uptake assay described above. After washing in PBS the cells were fixed with 4% 
PFA in PBS for 15 min. The cells were then washed again with PBS and permeabilized 
using Triton X-100 in TBS. The actin cytoskeleton was stained with Alexa 647 
phalloidin. The cells were then washed in TRIS buffered saline (TBS), resuspended in 
ProLong Gold anti-fade mounting medium containing DAPI on glass slides, and 
overlaid with glass coverslips. The cells were then allowed to set at room temperature 
in the dark overnight. Cells were imaged with a Delta Vision Spectris microscope, and 
the image stacks were deconvolved with the Delta Vision SoftWorks software. The 
deconvolved stacks of images taken through the cells were then further analysed with 
ImageJ software.  
 
Western blot analysis (paper I and paper II) 
 
In paper I and paper II Western blot analysis was performed in order to study 
phosphorylation status of ERK and MAPKAP2 (paper I) Western blotting was also 
used to confirm the presence of gelsolin in wild-type DC as well as absence of gelsolin 
in gelsolin-deficient DC (paper II). 
 
In order to detect gelsolin, day 6 DC derived from wild-type or gelsolin-deficient mice 
were analysed. The DC were, without prior treatment, prepared in sample buffer, 
separated on gel, transferred to membranes, and stained with anti-gelsolin antisera. To 
assess the activation status of the ERK and P38 MAPK pathways, DC were activated 
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with LPS for the indicated time points at 37°C or 28°C. The cells were then prepared in 
sample buffer, separated on gel, transferred to membranes, and stained anti-phospho-
ERK or anti-phospho-MAPKAPK2 antisera. Equal loading was confirmed by actin 
staining. The chemiluminescent signals were captured with a digital LAS 4000 system 
(Fuji Film Life Science), and the signal intensity was analysed with ImageJ software 
(http://rsbweb.nih.gov/ij/).  
 
Podosome visualization and evaluation  (paper I and paper II)  
 
In paper I, sterilized glass coverslips were placed in bottom of each well of 24 well 
tissue culture plates, and cell suspensions containing day 6 DC were added. The cells 
were then incubated at 37°C or 28°C after which the cells were fixed for 15 min using 
pre-warmed (37°C) 4% PFA. The actin cytoskeleton was stained with phalloidin 
followed by a step of extensive washing, using PBS. In paper II, the podosomes were 
visualized by vinculin staining using an FITC anti-vinculin antibody followed by 
staining of the actin cytoskeleton with TRITC-phalloidin. The staining procedures were 
followed by extensive washing using PBS. The coverslips were then mounted with 
ProLong Gold antifade containing DAPI. The morphology of the actin cytoskeleton 
and the podosome structures were observed using a Delta Vision Spectris microscope 
and analysed with ImageJ software. The percentage of DC that exhibited podosome 
structures was calculated. To visualize and evaluate the capacity of podosomes to 
assemble and disassemble in paper II, DC from gelsolin-deficient and wild-type mice 
were transduced with a GFP-actin encoding retrovirus. The DC were then seeded in 
glass-bottom petri dishes and monitored using a DeltaVision Spectris live cell imaging 
system. The podosome lifetime was quantified from the videos obtained using the 
MTrackJ analysis plugin for ImageJ software (http://imagej.nih.gov/ij/). 
 
Extra-cellular matrix (ECM)-degrading capacity (paper I and paper II) 
 
The capacity of podosomes to degrade extracellular matrix was evaluated using a 
model in which degradation of fluorescent gelatin is measured and quantified. This 
approch has previously been described [192], although some modifications were made 
for the present study. Ethanol-sterilized coverslips were coated with Oregon-green 
gelatin. After an extensive washing procedure to remove PFA, used to stabilize the 
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gelatin, a day 6 DC cell suspension was added onto the gelatin-coated coverslips and 
incubated overnight before fixing. Then the cells were stained with phalloidin and 
mounted as described above. Images were acquired using a Delta Vision Spectris 
microscope. In paper II, the percentage of the image area that lacked a fluorescent 
signal from the Oregon-green gelatin, i.e., degradation as result of podosome function 
was analysed and quantified using ImageJ software.  
 
Transmission electron microscopy of the podosome ultra-structure (paper I) 
 
In paper II, the ultra-structure of the podosomes expressed in gelsolin-deficient DC 
compared to the wild-type was assessed using transmission electron microscopy 
(TEM).  The cytoskeleton connected to the ventral cell surface membrane of the DC 
was prepared as previously described [193], with some modifications. In brief, ventral 
membrane preparations were made by mechanical fragmentation of the cells 
(”unroofing”) followed by fixation. The samples were rapidly frozen on a helium-
cooled block, freeze-dried, rotary shadowed with either platinum to tantalum-tungsten, 
and stabilized with 5 nm of carbon without rotation. The preparations were picked up 
on grids and viewed in the EM at 80 kV. 
 
Migration assay (paper I and paper II) 
 
In order to study migration, two transwell systems were used in paper I.  Transwell 
membrane inserts were coated with a thin layer of Matrigel, just covering the filter area, 
or they were left untreated. In the uncoated transwell system the DC could freely 
migrate from the insert to the lower chamber, whereas in the Matrigel-coated system, 
the cells needed to degrade and penetrate the Matrigel in order to reach the lower 
chamber. Thus, this system provides a functional readout of the collagenolytic activity 
of the cells, followed by migration. The cells were harvested and seeded into the 
transwell inserts, and then incubated for the indicated times. The cells that had migrated 
to the lower chamber were counted in Bürker-chambers using trypan blue exclusion. In 
paper II, only the Matrigel coated system was used, and the cells counted Bürker-
chambers and flow-cytometry. The cells were stained with anti-CD11c mAb and 
analysed by flow cytometry using a FACSCalibur cytometer and CellQuest software. 
 
 
  33 
Evaluation of the cell surface expression, of DC maturation markers (paper I) 
 
The DC were activated with LPS as described above and incubated overnight at 37°C 
or 28°C. The Fc receptors were blocked using 2.4G2 Fc blocking antibody before 
staining for the flow cytometric analysis. The cells were stained with anti-CD40 PE, 
anti-CD86 FITC and anti-CD11c Alexa 647. All stainings were performed on ice, after 
which the cells were washed and analysed by flow cytometry using a FACSCalibur 
cytometer and CellQuest software. 
 
Antigen processing and presentation (paper I) 
 
To measure antigen processing and the subsequent loading of peptides onto MHC class 
II at different temperatures, Hen egg lysozyme (HEL) and DC from C3H/HeN mice (I-
Ak) were used. Different concentrations of HEL were used and the DC were either 
activated using LPS or they were left untreated. The DC were then incubated overnight 
at 37°C or 28°C, after which the cell surface expression of I-Ak/HEL (46–61) peptide 
was measured by staining with Alexa 647-conjugated C4H3 mAb, which recognizes 
this peptide-MHC class II complex [169]. The DC were analysed using a FACSCalibur 
cytometer and CellQuest software. 
 
T-cell proliferation assay (paper I) 
 
To study whether or not low physiological temperature affects the capacity of DC to 
induce T cell proliferation, the DC were incubated with ovalbumin (OVA) in the 
presence of LPS at 28°C or 37°C for 4 hours. The DC were then washed and seeded 
into 96-well plates at different concentrations in triplicate. The T cell receptor-
transgenic OT-II T cells were added to the wells, and the cells were incubated at 37°C 
for 72 hours. Importantly, the T cells were not exposed to lower temperatures. 
Allogenic stimulation was performed using bone marrow derived DC from C57BL/6 
mice and C3H/HeN spleen CD4+ T cells. The allogenic DC were seeded into 96-well 
plates in triplicates. The DC were stimulated with LPS or left untreated for 4 hours at 
28°C or 37°C and then, the DC were then washed extensively, after which purified 
CD4+ T cells were added, and incubated at 37°C for 72 hours. Then, [3H]thymidine was 
added to each well of the T-cell cultures during the last 16 h. The cells were harvested 
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with a TOMTEC cell harvester onto filters, and scintillation sheets were added. The T 
cell proliferation was then measured using a !-counter. 
 
Ethics statement 
 
All animal experiments were performed in accordance with national and institutional 
guidelines. In papers I-III the experiments were approved by the Stockholm Animal 
Ethical Committee North (Stockholms Norra Djurförsöksetiska Nämnd), application 
numbers; N269/07 and N64/11. In paper II, the wild-type and gelsolin knock-out mice 
were bred and used in accordance with the guidelines at the Translational Medicine 
Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical 
School, Boston, Massachusetts, USA, or at the Institute of Genetics, University of 
Bonn, Bonn, Germany. Moreover, in paper III, the MyD88 and TRIF knock-out mice 
were bred and used in accordance with the guidelines at the Immunobiology 
Laboratory, London Research Institute, Lincoln’s Inn Fields Laboratories, London.   
 
Statistical analysis 
 
In paper I, the statistical analysis was performed using the single factor ANOVA test 
plugin in Microsoft Excel. In Papers II and III, the statistical analysis was performed 
using Graphpad Prism v.5 software and the two-tailed non-parametric Mann-Whitney 
test.  
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